Blog
RSS FeedPosted by Michael Wonder on 08 Jan 2021
FDA statement on following the authorised dosing schedules for COVID-19 vaccines
4 January 2021 - Two different mRNA vaccines have now shown remarkable effectiveness of about 95% in preventing COVID-19 disease ...
Posted by Michael Wonder on 03 Nov 2020
Is it time for the FDA to be independent?
3 November 2020 - Public health experts and lay observers alike have expressed concerns that, under political pressure, the FDA ...
Posted by Michael Wonder on 19 Aug 2020
US may need to look to Germany to reform drug pricing
19 August 2020 - US administrative and legislative efforts are moving the United States and Germany more into alignment on drug ...
Posted by Michael Wonder on 15 Oct 2019
Congress should set fair rules that force drug corporations to negotiate prices
14 October 2019 - As a pastor, I am deeply invested in the health and well being of my community. ...
Posted by Michael Wonder on 12 Sep 2019
New rules will keep the best medications from desperate Canadians
12 September 2019 - One reaction to recent amendments to the rules of the federal Patented Medicine Prices Review Board, ...
Posted by Michael Wonder on 07 May 2019
Trump directs Azar to work on Florida drug import plan
6 May 2019 - President Donald Trump on Monday directed Health and Human Services Secretary Alex Azar to work with ...
Posted by Michael Wonder on 26 Feb 2019
'Wacky' drug price system keeps costs high for patients paying for prescriptions, FDA chief says
26 February 2019 - "The sick people are helping to subsidise the healthy people. That's not how insurance is supposed to ...
Posted by Michael Wonder on 21 Nov 2018
Sanders unveils aggressive new bill targeting drug prices
20 November 2018 - Sen. Bernie Sanders and Rep. Ro Khanna on Tuesday unveiled a bill aimed at aggressively lowering ...
Posted by Michael Wonder on 15 Apr 2018
Drug company ‘shenanigans’ to block generics come under federal scrutiny
14 April 2018 - Trump administration officials, seeking ways to lower drug costs, are targeting pharmaceutical companies that refuse to ...
Posted by Michael Wonder on 15 Mar 2018
Product withdrawn after overseas reports of inflammatory brain disorders
15 March 2018 - Consumers and health professionals are advised that Biogen Australia, in consultation with the TGA, will withdraw ...
Posted by Michael Wonder on 01 Feb 2018
Advance notice of consultation about changes to the Pharmaceutical Schedule Rules
1 February 2018 - PHARMAC is working to make the Pharmaceutical Schedule Rules easier to find, use and apply. ...
Posted by Michael Wonder on 30 Nov 2017
U.S. Government should negotiate drug prices, adviser group says
30 November 2017 - National Academies releases report with recommendations. ...
Posted by Michael Wonder on 20 Nov 2017
EMA to relocate to Amsterdam, the Netherlands
20 November 2017 - Agency to begin working immediately with Dutch government to ensure successful move by end of March ...
Posted by Michael Wonder on 20 Oct 2017
MHRA chief floats faster reviews, closer ties to NICE
19 October 2017 - The head of the United Kingdom’s regulatory agency has sketched out some of the ways it ...
Posted by Michael Wonder on 11 Jul 2017
FDA speeding generic drug approvals: not just lip service
10 July 2017 - May and June 2017 have seen the most generic drug approvals since the US FDA began ...